The stock of Evolus Inc (NASDAQ: EOLS) has decreased by -8.00 when compared to last closing price of 10.37.Despite this, the company has seen a loss of -16.24% in its stock price over the last five trading days. businesswire.com reported 2025-03-25 that NEWPORT BEACH, Calif.–(BUSINESS WIRE)–Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio, today announced that members of its management team will participate in a fireside chat and investor meetings at the upcoming Needham Annual Virtual Healthcare Conference. The fireside chat will take place on Tuesday, April 8, 2025, at 12:45 PM ET – Track 1. The fireside chats can be accessed on the Investor Relations page of the Evolus website here.
Is It Worth Investing in Evolus Inc (NASDAQ: EOLS) Right Now?
Moreover, the 36-month beta value for EOLS is 1.15. Analysts have varying opinions on the stock, with 3 analysts rating it as a “buy,” 3 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for EOLS is 56.11M and currently, short sellers hold a 12.75% of that float. On April 10, 2025, EOLS’s average trading volume was 841.35K shares.
EOLS’s Market Performance
EOLS’s stock has seen a -16.24% decrease for the week, with a -28.91% drop in the past month and a -6.56% fall in the past quarter. The volatility ratio for the week is 13.07%, and the volatility levels for the past 30 days are at 6.51% for Evolus Inc. The simple moving average for the past 20 days is -20.43% for EOLS’s stock, with a -29.54% simple moving average for the past 200 days.
Analysts’ Opinion of EOLS
Many brokerage firms have already submitted their reports for EOLS stocks, with Barclays repeating the rating for EOLS by listing it as a “Overweight.” The predicted price for EOLS in the upcoming period, according to Barclays is $16 based on the research report published on January 29, 2024 of the previous year 2024.
Needham, on the other hand, stated in their research note that they expect to see EOLS reach a price target of $18. The rating they have provided for EOLS stocks is “Buy” according to the report published on June 23rd, 2022.
Barclays gave a rating of “Equal Weight” to EOLS, setting the target price at $10 in the report published on May 12th of the previous year.
EOLS Trading at -27.29% from the 50-Day Moving Average
After a stumble in the market that brought EOLS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -46.46% of loss for the given period.
Volatility was left at 6.51%, however, over the last 30 days, the volatility rate increased by 13.07%, as shares sank -26.43% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -34.51% lower at present.
During the last 5 trading sessions, EOLS fell by -16.29%, which changed the moving average for the period of 200-days by -9.28% in comparison to the 20-day moving average, which settled at $11.99. In addition, Evolus Inc saw -13.59% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at EOLS starting from MOATAZEDI DAVID, who sale 6,251 shares at the price of $12.40 back on Mar 27 ’25. After this action, MOATAZEDI DAVID now owns 508,619 shares of Evolus Inc, valued at $77,512 using the latest closing price.
Avelar Rui, the of Evolus Inc, sale 27,904 shares at $13.26 during a trade that took place back on Mar 18 ’25, which means that Avelar Rui is holding 362,467 shares at $369,868 based on the most recent closing price.
Stock Fundamentals for EOLS
Current profitability levels for the company are sitting at:
- -0.12 for the present operating margin
- 0.67 for the gross margin
The net margin for Evolus Inc stands at -0.19. The total capital return value is set at -0.18. Equity return is now at value -861.68, with -23.92 for asset returns.
Based on Evolus Inc (EOLS), the company’s capital structure generated 0.96 points at debt to capital in total, while cash flow to debt ratio is standing at -0.14. The debt to equity ratio resting at 23.54. The interest coverage ratio of the stock is -1.67.
Currently, EBITDA for the company is -25.0 million with net debt to EBITDA at -0.96. When we switch over and look at the enterprise to sales, we see a ratio of 2.4. The receivables turnover for the company is 5.58for trailing twelve months and the total asset turnover is 1.14. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.40.
Conclusion
To wrap up, the performance of Evolus Inc (EOLS) has been bad in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
